Updating results

81 results for dyspepsia Sort: Relevance | Date

Dyspepsia and gastro-oesophageal reflux disease

Everything NICE has said on investigating and managing dyspepsia and gastro-oesophageal reflux disease in an interactive flowchart

NICE Pathway Published September 2014 Last updated October 2018

Suspected cancer recognition and referral

Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

NICE Pathway Published June 2015 Last updated August 2018

Idiopathic pulmonary fibrosis in adults: diagnosis and management (CG163)

Evidence-based recommendations on diagnosing and managing idiopathic pulmonary fibrosis (IPF) (hardening of the lungs) in adults

Clinical guideline Published June 2013 Last updated May 2017

Barrett's oesophagus: ablative therapy (CG106)

Evidence-based recommendations on care and treatment of adults having ablative therapy to treat Barrett’s oesophagus with high-grade dysplasia…

Clinical guideline Published August 2010

Non-Hodgkin's lymphoma: diagnosis and management (NG52)

Evidence-based recommendations on diagnosing and managing non-Hodgkin's lymphoma in people aged 16 years and over

NICE guideline Published July 2016

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)

Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published March 2012

Pirfenidone for treating idiopathic pulmonary fibrosis (TA504)

Evidence-based recommendations on pirfenidone (Esbriet) for idiopathic pulmonary fibrosis (IPF) in adults

Technology appraisal guidance Published February 2018

Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (CG68)

Evidence-based recommendations on the diagnosis and initial management of stroke and transient ischaemic attack (TIA or ‘mini-stroke’) in over 16s

Clinical guideline Published July 2008 Last updated March 2017

ESUOM12: Generalised anxiety disorder: quetiapine

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Catheterless oesophageal pH monitoring (IPG187)

Evidence-based recommendations on catheterless oesophageal pH monitoring (placing small wireless capsule in gullet to check the level of acid)

Interventional procedures guidance Published July 2006

ESUOM22: Bile acid malabsorption: colesevelam

Summary of the evidence on colesevelam for treating bile acid malabsorption (BAM) to inform local NHS planning and decision-making

Evidence summary Published October 2013

ESUOM13: Gastroparesis in adults: oral erythromycin

Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making

Evidence summary Published June 2013

ESUOM18: Promoting tolerance of enteral feeds in children and young people: domperidone

Summary of the evidence on domperidone to promote tolerance of enteral feeds in children and young people..

Evidence summary Published July 2013 Last updated September 2014

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease (IPG222)

Evidence-based recommendations on endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for gastro-oesophageal reflux

Interventional procedures guidance Published June 2007

MIB31: Peptest for diagnosing gastro‑oesophageal reflux

Advice on the use of the Peptest for diagnosing gastro-oesophageal reflux disease (GORD) to aid local decision-making

Medtech innovation briefing Published May 2015

Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease (IPG585)

Evidence-based recommendations on laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease (GORD) in adults

Interventional procedures guidance Published July 2017

ESUOM42: Digital ulcers: sildenafil

Summary of the evidence on sildenafil for managing digital ulcers to inform local NHS planning and decision-making

Evidence summary Published March 2015

ESUOM23: Transient ischaemic attack: clopidogrel

Summary of the evidence on clopidogrel for treating transient ischaemic attack (TIA) to inform local NHS planning and decision-making

Evidence summary Published December 2013

Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women (TA160)

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance Published October 2008 Last updated February 2018

ESNM69: Prevention of chemotherapy induced nausea and vomiting in adults: netupitant/palonosetron

Summary of the evidence on netupitant/palonosetron to prevent chemotherapy induced nausea and vomiting to inform local NHS planning and decision-making

Evidence summary Published March 2016

Head and neck cancer (QS146)

Evidence-based statements to deliver quality improvements in assessing, diagnosing and managing head and neck cancer in people aged 16 and over

Quality standard Published March 2017

Cerebral palsy in under 25s: assessment and management (NG62)

Evidence-based recommendations on diagnosing, assessing and managing cerebral palsy in children and young people under 25

NICE guideline Published January 2017

Irritable bowel syndrome in adults: diagnosis and management (CG61)

Evidence-based recommendations on diagnosing and managing irritable bowel syndrome (IBS) in adults

Clinical guideline Published February 2008 Last updated April 2017

Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (TA161)

Evidence-based recommendations on raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance Published October 2008 Last updated February 2018

MIB104: NaviCam for diagnosing gastrointestinal tract conditions

Advice on the use of NaviCam for diagnosing gastrointestinal (GI) tract and small bowel conditions to aid local decision-making

Medtech innovation briefing Published May 2017

Past appeals and decisions

- collagenase clostridium histolyticum 30 November 2015 TA007 Dyspepsia - proton pump inhibitors 29 June 2000 TA059 Electroconvulsive...

Published May 2018

Osteoporosis (QS149)

Evidence-based statements to deliver quality improvements in managing osteoporosis in adults, including assessing risk and preventing fragility fractures

Quality standard Published April 2017

Infliximab for acute exacerbations of ulcerative colitis (TA163)

Evidence-based recommendations on infliximab (Remicade) for acute exacerbations of ulcerative colitis in adults

Technology appraisal guidance Published December 2008

ESUOM37: Cystic fibrosis: long-term azithromycin

Summary of the evidence on long-term azithromycinoral for treating cystic fibrosis (CF) to inform local NHS planning and decision-making

Evidence summary Published November 2014

ESUOM19: Schizophrenia: omega-3 fatty acid medicines

Summary of the evidence on omega-3 fatty acid medicines for treating schizophrenia to inform local NHS planning and decision-making

Evidence summary Published September 2013

Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (TA275)

Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation (AF)

Technology appraisal guidance Published February 2013

Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)

Evidence-based recommendations on rivaroxaban (Xarelto) for preventing stroke and systemic embolism in atrial fibrillation (AF)

Technology appraisal guidance Published May 2012

ESUOM11: Induction of labour in late intrauterine fetal death: vaginal misoprostol (after oral mifepristone)

Summary of the evidence on vaginal misoprostol (after oral mifepristone) for induction labour in late intrauterine fetal death (IUFD)..

Evidence summary Published April 2013

Osteoporosis

Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart

NICE Pathway Published August 2012 Last updated February 2018

ES8: Narcolepsy with or without cataplexy in adults: pitolisant

Summary on the evidence on pitolisant for treating narcolepsy with or without cataplexy to inform local NHS planning and decision-making

Evidence summary Published March 2017

ESNM18: Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil

Summary of the evidence on tadalafil for lower urinary tract symptoms secondary to benign prostate hyperplasia..

Evidence summary Published May 2013 Last updated October 2013

ESNM61: Orthostatic hypotension due to autonomic dysfunction: midodrine

Summary of the evidence on midodrine for orthostatic hypotension due to autonomic dysfunction to inform local NHS planning and decision-making

Evidence summary Published October 2015